Updated:
Padda Health
Padda Health was established in 2008 by Carlo Giovanni Conti and Giuseppe Giannachi. The firm operates as a multi-family office from its headquarters in Milan...
Padda Health
Padda Health was established in 2008 by Carlo Giovanni Conti and Giuseppe Giannachi. The firm operates as a multi-family office from its headquarters in Milan and focuses on life-science and digital-health investments. It targets seed and startup rounds in diagnostics, medical devices and health software. Deployment occurs through direct co-investments and SPVs. Confirmed co-investors include Invitalia and Finalca, the family office of the Cazzola family. Portfolio activity has included GenomeUp and PatchAI, the latter acquired by Alira Health. Geographic reach centers on Italy with additional exposure to other European markets. Technology emphasis includes AI/ML and biotech applications. No public data exist on assets under management, team size or additional offices. EIT Health has appeared as a co-investor on select opportunities. No operational events from the last 24 months appear in available records.
General information
Firm type
Multi Family Office
Year founded
2008
Location
Region
Europe
Country
Italy
City
Milan
Corporate office
Via Sant'Antonio 4, 20122 Milan, Italy
Principals
Carlo Giovanni Conti
Partner
Giuseppe Giannachi
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Padda Health?
Carlo Giovanni Conti and Giuseppe Giannachi serve as partners and make investment decisions. Both are listed as founders in the firm's records.
How does Padda Health source proprietary deal flow?
The firm relies on sector relationships within Italy and Europe. It has partnered with national agencies such as Invitalia and innovation communities such as EIT Health.
Does Padda Health participate in fund commitments or only direct deals?
Padda Health uses direct co-investments and SPVs. No fund commitments are recorded in available data.
What investment stages does Padda Health typically target?
The firm targets seed and startup rounds. It supports companies in diagnostics, medical devices and health software.
Where does the underlying wealth come from?
Wealth origin is not publicly disclosed beyond the multi-family office structure.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: